Sunu Thomas, MD
Advanced Heart Failure and Transplant Cardiology · Seattle, WANPI 1013202662
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Abbott at 34.1% of the total. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in WA, where the typical reported total is $3,028.
Across 18 payments — averaging $106.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$654
- Abiomed$509
- Ancora Heart, Inc.$215
- Boston Scientific$201
- Medtronic$198
- Livanova USA, Inc.$127
- plus $15 from 1 others
Across 5 payments — averaging $2166.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$11K
What the payments were for
- Food & beverage$1,919100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $654 |
| Abiomed | 5 | $509 |
| Ancora Heart, Inc. | 1 | $215 |
| Boston Scientific | 2 | $201 |
| Medtronic(2 entities) | 3 | $198 |
| Livanova USA, Inc. | 1 | $127 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,919 in reported general payments places this provider in the 35th percentile of 20 advanced heart failure and transplant cardiology providers in Washington.
See all advanced heart failure and transplant cardiology providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 56 | $87,771 |
| JardianceEmpagliflozin | 31 | $52,568 |
| EliquisApixaban | 19 | $29,710 |
| Sirolimus | 24 | $9,601 |
| Tacrolimus | 49 | $4,449 |
| Mycophenolate Mofetil | 16 | $1,942 |
| Mycophenolic AcidMycophenolate Sodium | 12 | $1,486 |
| Rosuvastatin Calcium | 59 | $1,137 |
| Dapsone | 15 | $847 |
| Metoprolol Succinate | 40 | $720 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 44 | $604 |
| Amlodipine Besylate | 37 | $382 |
| Torsemide | 11 | $378 |
| Pantoprazole Sodium | 31 | $365 |
| Losartan Potassium | 38 | $359 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Seattle
- Wayne LevySeattle$275K
- John MignoneSeattle$19K
- Preethi PirlamarlaSeattle$14K
- Salpy PamboukianSeattle$5K
- James ZhangSeattle$3K
- April Stempien OteroSeattle$2K
- Richard ChengSeattle$759
- Elina MinamiSeattle$698
- Daniel FishbeinSeattle$600
- Kevin ObrienSeattle$222
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.